Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

SANUWAVE Health, Inc. (SNWV)

$5.93 +0.17% NASDAQ: SNWV · 15-min delayed
  • EDEN PRAIRIE, Minnesota
  • Public · NASDAQ: SNWV
  • 55 employees
$126.9MMarket cap
$44.1MRevenue · FY2025
$11.8MNet income
55Employees
SNWVNASDAQ
2008IPO

About SANUWAVE Health, Inc.

SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$44.1M
Net income
$11.8M
Total assets
$37.3M
Market cap
$126.9M
Gross margin
77.1%
Operating margin
11.2%
Net margin
26.8%

Source: SEC EDGAR · updated Jun 7, 2026

FY 2025

Financial statements

Income statement

Revenue
$44.1M
Cost of revenue
$10.1M
Gross profit
$34.0M
Operating expenses
$29.0M
Operating income
$4.9M
Income tax
$86.0K
Net income
$11.8M
EPS (basic)
$1.38
EPS (diluted)
$0.41

Balance sheet

Total assets
$37.3M
Current assets
$24.6M
Total liabilities
$35.7M
Current liabilities
$17.8M
Shareholders’ equity
$1.6M

Cash flow

Operating cash flow
$3.9M
Investing cash flow
$3.4M
Financing cash flow
-$5.6M
Net cash flow
$1.7M

Statements via Polygon.io (SEC filings)

NASDAQ: SNWV
$5.93 +0.17%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.92 $45.00

52-week range

Market cap
$126.9M
P/E ratio
14.5
EPS (diluted)
$0.41
Shares outstanding
21.4M
Open
Day range
Prev close
Volume
IPO date
Oct 8, 2008

SANUWAVE Health, Inc. (SNWV) Stock Price

  • Profitable — net income of $11.8M in FY2025.
  • Gross margin of 77.1%, net margin 26.8%.
  • Trading 87% below its 52-week high.
  • Valued at a price-to-earnings (P/E) ratio of 14.5.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review SANUWAVE Health, Inc..

Write a review
Newsroom

News about SANUWAVE Health, Inc.

News & sentiment via Polygon.io

FAQ

SANUWAVE Health, Inc.: frequently asked questions

Is SANUWAVE Health, Inc. an American company?

SANUWAVE Health, Inc. is a US-based company headquartered in Eden Prairie, Minnesota, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is SANUWAVE Health, Inc. headquartered?

SANUWAVE Health, Inc. is headquartered in Eden Prairie, Minnesota, United States.

Is SANUWAVE Health, Inc. publicly traded?

Yes — SANUWAVE Health, Inc. is a publicly traded company. Its stock trades under the ticker symbol SNWV on the NASDAQ.

What does SANUWAVE Health, Inc. do?

SANUWAVE Health, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →